ALBA BIOSCIENCE, INC. - ALBACYTE A1 CELLS, ALBACYTE B CELLS, ALBACYTE IGG SENSITIZED CELLS, AND ALBACYTE ANTIBODY SCREEN (3-CELLS)

PIID: HT940624F0146Solicitation ID: HT940624Q0087

Signed Date: Nov 12, 2025Effective Date: Oct 1, 2024End Date: Closes in 85 days

Award $

$22K

Vendor

ALBA BIOSCIENCE, INC.

NAICS

325413

Signed Date

Nov 12, 2025

Key Details

Dollars Obligated

$21,949.2

Base & All Options

Awarding Agency

Department of Defense

Awarding Sub-Agency

Defense Health Agency

NAICS Code

325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Product Service Code

6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

JACKSONVILLE, FL, 322145005, CD-FL-04

Description

ALBACYTE A1 CELLS, ALBACYTE B CELLS, ALBACYTE IGG SENSITIZED CELLS, AND ALBACYTE ANTIBODY SCREEN (3-CELLS)

Context & Analysis

On Nov 12, 2025, Department of Defense obligated $21,949.2 to ALBA BIOSCIENCE, INC. for albacyte a1 cells, albacyte b cells, albacyte igg sensitized cells, and albacyte antibody screen (3-cells). The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in JACKSONVILLE, FL. The contract is scheduled through Sep 2, 2026 — approximately 3 months remaining.